Logo image of MCRI

MONARCH CASINO & RESORT INC (MCRI) Stock Fundamental Analysis

USA - NASDAQ:MCRI - US6090271072 - Common Stock

95.23 USD
-1.08 (-1.12%)
Last: 10/15/2025, 8:00:01 PM
95.23 USD
0 (0%)
After Hours: 10/15/2025, 8:00:01 PM
Fundamental Rating

7

Overall MCRI gets a fundamental rating of 7 out of 10. We evaluated MCRI against 135 industry peers in the Hotels, Restaurants & Leisure industry. MCRI has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MCRI has a correct valuation and a medium growth rate. With these ratings, MCRI could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

MCRI had positive earnings in the past year.
In the past year MCRI had a positive cash flow from operations.
MCRI had positive earnings in each of the past 5 years.
In the past 5 years MCRI always reported a positive cash flow from operatings.
MCRI Yearly Net Income VS EBIT VS OCF VS FCFMCRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

MCRI has a Return On Assets of 11.15%. This is amongst the best in the industry. MCRI outperforms 87.41% of its industry peers.
MCRI has a better Return On Equity (14.59%) than 73.33% of its industry peers.
MCRI has a better Return On Invested Capital (17.60%) than 88.15% of its industry peers.
MCRI had an Average Return On Invested Capital over the past 3 years of 16.41%. This is significantly above the industry average of 10.67%.
The last Return On Invested Capital (17.60%) for MCRI is above the 3 year average (16.41%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 11.15%
ROE 14.59%
ROIC 17.6%
ROA(3y)11.75%
ROA(5y)9.74%
ROE(3y)15.45%
ROE(5y)13.62%
ROIC(3y)16.41%
ROIC(5y)13.04%
MCRI Yearly ROA, ROE, ROICMCRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With an excellent Profit Margin value of 14.72%, MCRI belongs to the best of the industry, outperforming 87.41% of the companies in the same industry.
MCRI's Profit Margin has improved in the last couple of years.
MCRI's Operating Margin of 24.09% is amongst the best of the industry. MCRI outperforms 88.15% of its industry peers.
MCRI's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 54.43%, MCRI is in the better half of the industry, outperforming 64.44% of the companies in the same industry.
MCRI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 24.09%
PM (TTM) 14.72%
GM 54.43%
OM growth 3Y-1.11%
OM growth 5Y7.55%
PM growth 3Y-7%
PM growth 5Y1.78%
GM growth 3Y-0.78%
GM growth 5Y1.1%
MCRI Yearly Profit, Operating, Gross MarginsMCRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), MCRI is creating value.
MCRI has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MCRI has more shares outstanding
There is no outstanding debt for MCRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MCRI Yearly Shares OutstandingMCRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
MCRI Yearly Total Debt VS Total AssetsMCRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 8.66 indicates that MCRI is not in any danger for bankruptcy at the moment.
The Altman-Z score of MCRI (8.66) is better than 91.11% of its industry peers.
There is no outstanding debt for MCRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.66
ROIC/WACC2.02
WACC8.7%
MCRI Yearly LT Debt VS Equity VS FCFMCRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 0.73 indicates that MCRI may have some problems paying its short term obligations.
With a Current ratio value of 0.73, MCRI is not doing good in the industry: 62.22% of the companies in the same industry are doing better.
MCRI has a Quick Ratio of 0.73. This is a bad value and indicates that MCRI is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MCRI (0.67) is worse than 62.22% of its industry peers.
MCRI does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.73
Quick Ratio 0.67
MCRI Yearly Current Assets VS Current LiabilitesMCRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.30% over the past year.
The Earnings Per Share has been growing by 23.69% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 4.64% in the past year.
The Revenue has been growing by 15.95% on average over the past years. This is quite good.
EPS 1Y (TTM)24.3%
EPS 3Y12.04%
EPS 5Y23.69%
EPS Q2Q%21.01%
Revenue 1Y (TTM)4.64%
Revenue growth 3Y9.71%
Revenue growth 5Y15.95%
Sales Q2Q%6.84%

3.2 Future

The Earnings Per Share is expected to grow by 6.43% on average over the next years.
MCRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.33% yearly.
EPS Next Y12.21%
EPS Next 2Y9.04%
EPS Next 3Y6.43%
EPS Next 5YN/A
Revenue Next Year5.89%
Revenue Next 2Y5.04%
Revenue Next 3Y3.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MCRI Yearly Revenue VS EstimatesMCRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
MCRI Yearly EPS VS EstimatesMCRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

MCRI is valuated rather expensively with a Price/Earnings ratio of 17.90.
MCRI's Price/Earnings ratio is a bit cheaper when compared to the industry. MCRI is cheaper than 72.59% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.53, MCRI is valued a bit cheaper.
MCRI is valuated correctly with a Price/Forward Earnings ratio of 16.18.
MCRI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MCRI is cheaper than 71.11% of the companies in the same industry.
MCRI's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.04.
Industry RankSector Rank
PE 17.9
Fwd PE 16.18
MCRI Price Earnings VS Forward Price EarningsMCRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

MCRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MCRI is cheaper than 70.37% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MCRI is valued a bit cheaper than 79.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.68
EV/EBITDA 9.16
MCRI Per share dataMCRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
MCRI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.47
PEG (5Y)0.76
EPS Next 2Y9.04%
EPS Next 3Y6.43%

3

5. Dividend

5.1 Amount

MCRI has a Yearly Dividend Yield of 1.22%.
Compared to an average industry Dividend Yield of 6.99, MCRI pays a bit more dividend than its industry peers.
With a Dividend Yield of 1.22, MCRI pays less dividend than the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.22%

5.2 History

MCRI has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
MCRI Yearly Dividends per shareMCRI Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

28.06% of the earnings are spent on dividend by MCRI. This is a low number and sustainable payout ratio.
DP28.06%
EPS Next 2Y9.04%
EPS Next 3Y6.43%
MCRI Yearly Income VS Free CF VS DividendMCRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
MCRI Dividend Payout.MCRI Dividend Payout, showing the Payout Ratio.MCRI Dividend Payout.PayoutRetained Earnings

MONARCH CASINO & RESORT INC

NASDAQ:MCRI (10/15/2025, 8:00:01 PM)

After market: 95.23 0 (0%)

95.23

-1.08 (-1.12%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)07-16 2025-07-16/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners66.6%
Inst Owner Change0.33%
Ins Owners23.21%
Ins Owner Change1%
Market Cap1.74B
Analysts74.55
Price Target102.2 (7.32%)
Short Float %1.64%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield 1.22%
Yearly Dividend1.19
Dividend Growth(5Y)N/A
DP28.06%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.3)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.38%
Min EPS beat(2)4.02%
Max EPS beat(2)18.74%
EPS beat(4)4
Avg EPS beat(4)12.26%
Min EPS beat(4)4.02%
Max EPS beat(4)20.88%
EPS beat(8)5
Avg EPS beat(8)2.67%
EPS beat(12)6
Avg EPS beat(12)1.12%
EPS beat(16)9
Avg EPS beat(16)1.98%
Revenue beat(2)2
Avg Revenue beat(2)1.81%
Min Revenue beat(2)0.23%
Max Revenue beat(2)3.39%
Revenue beat(4)4
Avg Revenue beat(4)1.67%
Min Revenue beat(4)0.23%
Max Revenue beat(4)3.39%
Revenue beat(8)5
Avg Revenue beat(8)0.82%
Revenue beat(12)7
Avg Revenue beat(12)0.8%
Revenue beat(16)9
Avg Revenue beat(16)1.62%
PT rev (1m)0.8%
PT rev (3m)13.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.57%
EPS NY rev (1m)0.09%
EPS NY rev (3m)7.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.45%
Valuation
Industry RankSector Rank
PE 17.9
Fwd PE 16.18
P/S 3.25
P/FCF 16.68
P/OCF 11.7
P/B 3.23
P/tB 3.4
EV/EBITDA 9.16
EPS(TTM)5.32
EY5.59%
EPS(NY)5.89
Fwd EY6.18%
FCF(TTM)5.71
FCFY6%
OCF(TTM)8.14
OCFY8.55%
SpS29.27
BVpS29.52
TBVpS28.04
PEG (NY)1.47
PEG (5Y)0.76
Profitability
Industry RankSector Rank
ROA 11.15%
ROE 14.59%
ROCE 22.75%
ROIC 17.6%
ROICexc 20.14%
ROICexgc 21.3%
OM 24.09%
PM (TTM) 14.72%
GM 54.43%
FCFM 19.51%
ROA(3y)11.75%
ROA(5y)9.74%
ROE(3y)15.45%
ROE(5y)13.62%
ROIC(3y)16.41%
ROIC(5y)13.04%
ROICexc(3y)17.94%
ROICexc(5y)14.16%
ROICexgc(3y)18.89%
ROICexgc(5y)14.91%
ROCE(3y)21.22%
ROCE(5y)16.86%
ROICexcg growth 3Y10.75%
ROICexcg growth 5Y23.79%
ROICexc growth 3Y10.64%
ROICexc growth 5Y23.89%
OM growth 3Y-1.11%
OM growth 5Y7.55%
PM growth 3Y-7%
PM growth 5Y1.78%
GM growth 3Y-0.78%
GM growth 5Y1.1%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 83.34%
Cap/Sales 8.3%
Interest Coverage 156.5
Cash Conversion 81.68%
Profit Quality 132.59%
Current Ratio 0.73
Quick Ratio 0.67
Altman-Z 8.66
F-Score7
WACC8.7%
ROIC/WACC2.02
Cap/Depr(3y)95.66%
Cap/Depr(5y)184.37%
Cap/Sales(3y)9.04%
Cap/Sales(5y)17.42%
Profit Quality(3y)131.09%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.3%
EPS 3Y12.04%
EPS 5Y23.69%
EPS Q2Q%21.01%
EPS Next Y12.21%
EPS Next 2Y9.04%
EPS Next 3Y6.43%
EPS Next 5YN/A
Revenue 1Y (TTM)4.64%
Revenue growth 3Y9.71%
Revenue growth 5Y15.95%
Sales Q2Q%6.84%
Revenue Next Year5.89%
Revenue Next 2Y5.04%
Revenue Next 3Y3.33%
Revenue Next 5YN/A
EBIT growth 1Y9.89%
EBIT growth 3Y8.5%
EBIT growth 5Y24.7%
EBIT Next Year68.98%
EBIT Next 3Y20.95%
EBIT Next 5Y16.49%
FCF growth 1Y-20.42%
FCF growth 3Y4.73%
FCF growth 5YN/A
OCF growth 1Y-11.01%
OCF growth 3Y3.18%
OCF growth 5Y17.36%